We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Vols saber com serà la teva estada a l’Hospital Universitari Vall d’Hebron? Aquí trobaràs tota la informació.
Crohn’s disease is characterized by the expansion of mesenteric fat, also known as ‘‘creeping fat.’’ We explored the plasticity and immune properties of adipose-stem cells in the context of Crohn’s patients as potential key players in the development of creeping fat. Mesenteric adipose-stem cells from Crohn’s patients presented a more proliferative, inflammatory, invasive, and phagocytic phenotype than equivalent cells from healthy donors, irrespective of the clinical stage. Furthermore, we found that the inflammatory events that accounts Crohn’s disease alter DNA methylations of the adipose stem cells, influencing their anti-inflammatory and regenerative capacity. Finally, we demonstrated that mesenteric adipose tissue of Crohn’s patients is a bacterial reservoir, and it has a microbiome signature that is dependent on their clinical status. Interestingly, we studied Crohn’s patients from adipocentric point of view, that was poorly approached.
CV: Carolina Serena es llicenciada en Biologia per la Universitat Autònoma de Barcelona. Doctora per la Universitat Rovira i Virgili (URV) el 2007. Va desenvolupar la seva etapa postdoctoral al Weastmead Millenium Institute de Sydney, Austràlia. Durant aquesta etapa va participar com a investigadora en el projecte internacional "Phylogeny as a Base for Molecular Identification of Pathogenic Fungi" i com a professora d'un postgrau a la Universitat de Sydney. Actualment, es investigadora sènior I3 (prèviament Investigadora Ramon y Cajal), en l’Institut d’Investigació Sanitària Pere Virgili (IISPV), Hospital Joan XXIII de Tarragona dins del grup de Diabetes i Malalties Metabòliques Associades (DIAMET). La seva principal línia d’investigació és identificar els factors clau que intervenen en el desencadenament de la resposta immune innata del teixit adipós en la inflamació local o sistèmica en el context de l’obesitat i la malaltia de Crohn. Ha liderat un projecte associat al Ramon y Cajal, dos projectes FIS consecutius (PI15/00143 i PI18/00037) fruit dels quals ha sortit 1 patent (EP17382615.7.) i 5 publicacions en revistes de gran impacte en la seva àrea (destacant publicacions: com a primera autora/autora de corresponding: Serena C. Stem Cell Reports. 2017 Oct 10;9(4):1109-1123; Serena C. Clin Epigenetics. 2020 Apr 6;12(1):53). A més de dirigir la seva línia de recerca, la IP col·labora activament amb diverses línies del grup DIAMET, fruit de les quals han donat lloc a 7 publicacions d’alt índex d’impacte (destacant publicacions com: Serena C. ISME J. 2018 Jun;12(7):1642-1657 o Keiran N, Nat Immunol. 2019 May;20(5):581-592) i és co-inventora d’una patent del grup (PCT/EP2019/051157).
Inscriu-t'hi
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.